sibutramine has been researched along with Hypergonadotropic Hypogonadism in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, we demonstrated that sibutramine treatment had a favourable effect on body weight maintenance and obesity-related health risks." | 7.77 | Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks. ( Hainer, V; Hainerová, IA; Sedláčková, D; Zamrazilová, H, 2011) |
| " In addition, we demonstrated that sibutramine treatment had a favourable effect on body weight maintenance and obesity-related health risks." | 3.77 | Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks. ( Hainer, V; Hainerová, IA; Sedláčková, D; Zamrazilová, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hainerová, IA | 1 |
| Zamrazilová, H | 1 |
| Sedláčková, D | 1 |
| Hainer, V | 1 |
1 other study available for sibutramine and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks.
Topics: Adult; Appetite Depressants; Body Composition; Body Weight; Cyclobutanes; Gonadotropins; Homozygote; | 2011 |